Cadila Healthcare is reportedly planning to raise around Rs 1000 crore through a qualified institutional placement (QIP) of shares. The QIP, a capital-raising tool, is likely to open in the next two-three months.
Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.
